Mechanistic domains in canine corneal ulcer progression: a conceptual framework for adjunctive management
Author:
Open Access
- 19 June 2026
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Veterinary Science
- Vol. 13, 1825605
Abstract
Background: Canine corneal ulcers are commonly encountered in clinical practice and may progress to stromal melting and perforation if not appropriately managed. Adjunctive therapy has traditionally focused on collagenolysis inhibition and is often guided by morphological severity rather than dominant biological drivers. While anticollagenase strategies remain essential, ulcer progression involves interconnected processes, including inflammatory amplification, impaired epithelial repair, and ocular surface instability. This conceptual analysis therefore seeks to develop a mechanism-based conceptual framework that prioritizes these biological processes and guides adjunctive therapeutic decision-making. Methods: A targeted literature search was conducted using PubMed and Scopus for studies published between January 2000 and February 28, 2026. Relevant canine, animal model, and human studies were narratively synthesized to identify key pathophysiologic drivers and construct a mechanism-based hierarchical framework for adjunctive therapy. Interventions were categorized according to primary mechanistic targets and levels of supporting canine evidence. Results: The proposed framework delineates four therapeutic domains (Structural Preservation, Inflammatory Modulation, Regenerative Augmentation, and Functional Optimization) together with a meta-level component termed Precision Stratification. Structural Preservation, centered on protease inhibition, represents the highest biological priority in cases of active stromal melting. Inflammatory Modulation targets upstream amplification processes, whereas Regenerative Augmentation and Functional Optimization address epithelial repair and ocular surface stability, respectively. Precision Stratification is conceptualized as a meta-level decision-support component that aligns domain prioritization with dominant biological drivers. Evidence strength varies across domains; structural preservation strategies are supported by the broadest canine clinical evidence, whereas inflammatory modulation, regenerative, and precision-oriented strategies rely predominantly on translational or investigational data. Conclusion: The principal contribution of this work is the development of a mechanism-based hierarchical framework for adjunctive management of canine corneal ulcers. The framework preserves the central role of protease inhibition while situating it within a broader biologically structured model of corneal ulcer progression. Canine-specific validation of domain-targeted interventions and development of objective stratification tools represent important priorities for future investigation.Keywords
This publication has 33 references indexed in Scilit:
- Exosome as emerging therapeutic platform for wound healing: Current status, advancement and future crosstalkTissue and Cell, 2025
- Deep learning-based classification of fungal and Acanthamoeba keratitis using confocal microscopyThe Ocular Surface, 2025
- Topical pharmacologic treatments for dry eye disease: A systematic reviewThe Ocular Surface, 2025
- Healing the cornea: Exploring the therapeutic solutions offered by MSCs and MSC-derived EVsProgress in Retinal and Eye Research, 2024
- Application of OSA-VET® and qualiquantitative tear tests in brachycephalic dogs with and without keratoconjunctivitis siccaVeterinary Research Communications, 2024
- Recent advances in NLRP3 inflammasome in corneal diseases: Preclinical insights and therapeutic implicationsThe Ocular Surface, 2024
- Trends in using mesenchymal stromal/stem cells (MSCs) in treating corneal diseasesThe Ocular Surface, 2022
- Progress in corneal wound healingProgress in Retinal and Eye Research, 2015
- Clinical evaluation of pimecrolimus eye drops for treatment of canine keratoconjunctivitis sicca: A comparison with cyclosporine AThe Veterinary Journal, 2009
- Immunopathogenesis of Keratoconjunctivitis Sicca in the DogVeterinary Clinics of North America: Small Animal Practice, 2008